focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Diurnal shares more than double on takeover bid

Tue, 30th Aug 2022 11:04

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

----------

AIM - WINNERS

----------

Diurnal Group PLC, shares surge to 26.19 pence from Friday's close of 11.25p, 12-month range 9.5-67.9p. The pharmaceutical company focused on hormonal diseases agrees to be taken over by Neurocrine Biosciences Inc in deal worth GBP48.3 million. Neurocrine is offering 27.5p, cash, for each Diurnal share. Diurnal directors unanimously recommend deal. "We believe that the acquisition is compelling for Diurnal's shareholders given the risks associated with achieving Diurnal's vision of creating a profitable business, in particular the ongoing commercial roll out of Diurnal's products in Europe and the execution of key clinical studies, in addition to the substantial shareholder dilution that is likely to result from accessing the capital required to deliver this vision," says Non-Executive Chair Anders Harfstrand.

----------

SIMEC Atlantis Energy Ltd, up 31% at 2.03p, 12-month range 0.97p-5.3p. The sustainable energy generation firm secures necessary grid variations for the 230 megawatt/460 megawatt hour battery energy storage system at the Uskmouth site and has completed the novation of the grid connection agreement. "With excellent progress being made, the project is on track to be operational by 2024," it says. Adds it now has no loans outstanding with any SIMEC group company.

----------

MyCelx Technologies Corp, up 14% at 48.36p, 12-month range 30.55p-92.00p. The clean water and air technology firm secures new purchase order from SABIC Agri-Nutrients, a SABIC affiliate, to provide clean water for optimal performance in their fertiliser production process. Also wins short-term emergency response project with a independent petrochemical company in Saudi Arabia and secures renewal of two water treatment contracts with long-standing customers in the Middle East. "These projects underpin the 2022 revenue forecast, and the company remains on track to meet current guidance," it says.

----------

AIM - LOSERS

----------

Petroneft Resources PLC, down 28% at 0.645p, 12-month range 0.65p-4.88p. Reports temporary suspension of oil acceptance and transfer from Licence 61 by Nord Imperial LLC. In 2009, contract was signed with Nord Imperial to cover storage and transfer of oil by pipeline from Licence 61 to the Transneft Entry point at Zavyalovo. Petroneft says it has considered contract tariff to be "significantly higher than normal market rates" for some time. Says payments were made to Nord Imperial at reduced levels amid no progress in finding "more equitable" outcome and, in response, Nord Imperial has temporarily suspending the acceptance of oil and transfer. "As the company currently have no other export route from Licence 61, Petroneft is progressively shutting down its wells until the situation can be resolved," it says.

----------

Joules Group PLC, down 7.5% at 23.58p, 12-month range 19.41p-257.00p. Retailer insists it continues in "positive" discussions with Next over a possible investment, despite Sky News over the weekend reporting that talks had stalled. Sky News said it has learnt the two companies are not close to agreeing the terms of an investment from Next, and the FTSE 100-listed retailer had not received enough financial information to allow it to make a formal offer to the Joules board. There were also doubts that Next would want to proceed with a deal at 33p per share or more given Joules shares closed at 25.5p on Friday. The stock has fallen 82% since the start of 2022, and shares had closed at 33p the day before the companies confirmed they were in talks over the potential equity investment.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
21 Apr 2021 17:59

TRADING UPDATES: Diurnal taps GBP20 million; Victoria buys new assets

TRADING UPDATES: Diurnal taps GBP20 million; Victoria buys new assets

Read more
15 Apr 2021 19:37

TRADING UPDATES: HSBC announces redemption of US dollar securities

TRADING UPDATES: HSBC announces redemption of US dollar securities

Read more
26 Mar 2021 14:36

TRADING UPDATES: Renew to buy J Browne; Idox in good start to year

TRADING UPDATES: Renew to buy J Browne; Idox in good start to year

Read more
23 Feb 2021 16:23

Alkindi sales drive revenue higher for Diurnal

(Sharecast News) - Speciality pharmaceuticals company Diurnal reported 6% growth in first-half total revenue in its interim results on Tuesday, to £1.21m.

Read more
23 Feb 2021 12:28

UPDATE: Diurnal Loss Widens In First Half; Signs Chronocort Deal

UPDATE: Diurnal Loss Widens In First Half; Signs Chronocort Deal

Read more
23 Feb 2021 12:15

Diurnal Reports Widened Loss In First Half Despite Revenue Growth

Diurnal Reports Widened Loss In First Half Despite Revenue Growth

Read more
16 Feb 2021 15:58

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
27 Jan 2021 09:22

Diurnal Inks Licence Agreement For Alkindi With Citrine Medicine

Diurnal Inks Licence Agreement For Alkindi With Citrine Medicine

Read more
14 Jan 2021 19:15

UK TRADING UPDATE SUMMARY: DWF Sets Up New Global Operating Structure

UK TRADING UPDATE SUMMARY: DWF Sets Up New Global Operating Structure

Read more
14 Jan 2021 15:18

IN BRIEF: Diurnal Pleased With Alkindi Sales In First Half

IN BRIEF: Diurnal Pleased With Alkindi Sales In First Half

Read more
13 Jan 2021 14:36

IN BRIEF: Diurnal Inks Turkey Distribution Deal For Alkindi, Chronocort

IN BRIEF: Diurnal Inks Turkey Distribution Deal For Alkindi, Chronocort

Read more
12 Jan 2021 19:12

IN BRIEF: Diurnal Submits Application To UK Regulators For Chronocort

IN BRIEF: Diurnal Submits Application To UK Regulators For Chronocort

Read more
11 Jan 2021 13:22

IN BRIEF: Diurnal Inks European Patent For Chronocort

IN BRIEF: Diurnal Inks European Patent For Chronocort

Read more
20 Nov 2020 18:03

IN BRIEF: Diurnal Secures Grant Of European Patent For Alkindi

IN BRIEF: Diurnal Secures Grant Of European Patent For Alkindi

Read more
20 Nov 2020 12:04

Diurnal gets European patent for 'Alkindi'

(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced the grant of a patent for 'Alkindi', or hydrocortisone granules in capsules for opening, by the European Patent Office on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.